Your browser doesn't support javascript.
loading
DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity.
Du, Qian; Smith, Grady C; Luu, Phuc Loi; Ferguson, James M; Armstrong, Nicola J; Caldon, C Elizabeth; Campbell, Elyssa M; Nair, Shalima S; Zotenko, Elena; Gould, Cathryn M; Buckley, Michael; Chia, Kee-Ming; Portman, Neil; Lim, Elgene; Kaczorowski, Dominik; Chan, Chia-Ling; Barton, Kirston; Deveson, Ira W; Smith, Martin A; Powell, Joseph E; Skvortsova, Ksenia; Stirzaker, Clare; Achinger-Kawecka, Joanna; Clark, Susan J.
Afiliação
  • Du Q; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
  • Smith GC; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Luu PL; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
  • Ferguson JM; The Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Armstrong NJ; Mathematics and Statistics, Murdoch University, Murdoch, WA 6150, Australia.
  • Caldon CE; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
  • Campbell EM; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Nair SS; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
  • Zotenko E; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Gould CM; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Buckley M; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Chia KM; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Portman N; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Lim E; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
  • Kaczorowski D; Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Chan CL; Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Barton K; The Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Deveson IW; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia; The Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Smith MA; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia; The Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
  • Powell JE; Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; UNSW Cellular Genomics Futures Institute, School of Medical Sciences, UNSW Sydney, NSW 2010, Australia.
  • Skvortsova K; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
  • Stirzaker C; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
  • Achinger-Kawecka J; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
  • Clark SJ; Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia. Electronic address: s.clark@garvan.org.au.
Cell Rep ; 36(12): 109722, 2021 09 21.
Article em En | MEDLINE | ID: mdl-34551299
DNA replication timing and three-dimensional (3D) genome organization are associated with distinct epigenome patterns across large domains. However, whether alterations in the epigenome, in particular cancer-related DNA hypomethylation, affects higher-order levels of genome architecture is still unclear. Here, using Repli-Seq, single-cell Repli-Seq, and Hi-C, we show that genome-wide methylation loss is associated with both concordant loss of replication timing precision and deregulation of 3D genome organization. Notably, we find distinct disruption in 3D genome compartmentalization, striking gains in cell-to-cell replication timing heterogeneity and loss of allelic replication timing in cancer hypomethylation models, potentially through the gene deregulation of DNA replication and genome organization pathways. Finally, we identify ectopic H3K4me3-H3K9me3 domains from across large hypomethylated domains, where late replication is maintained, which we purport serves to protect against catastrophic genome reorganization and aberrant gene transcription. Our results highlight a potential role for the methylome in the maintenance of 3D genome regulation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genoma Humano / Metilação de DNA / Período de Replicação do DNA Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genoma Humano / Metilação de DNA / Período de Replicação do DNA Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália